JINGNAN HOU: Open Payments
NPI 1063964575 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 11 payments from 7 companies in 2025. Trend: 2023 $71 · 2024 $415 · 2025 $568
Food & beverage: $469Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $346 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Genentech USA, Inc. | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Celgene Corporation | 1 | $14 |
Products named: Niktimvo, BREYANZI, JAKAFI, Columvi, BRUKINSA, ZERBAXA, OJJAARA, REBLOZYL.
Industry payments across OH — which companies pay providers there.
